Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitaxsentan in Chronic Kidney Disease
NCT00810732Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Primary completion
- Mar 2009
- Countries
- 1
01
Overview
A Phase 2 trial of sitaxsentan in chronic kidney disease (CKD), sponsored by Pfizer. Started May 2007; status: completed.
02
Drugs
sitaxsentan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00810732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810732.